$DLB

Nicholson Ryan sold $84K of DLB

Nicholson Ryan (VP, CAO and Corp. Controller) sold 1,348 shares of Dolby Laboratories, Inc. (DLB) at $62.04 on 2026-08-10.

Original reporting
SEC EDGAR · Nicholson Ryan
Published Aug 12, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not provide new company fundamentals or forward-looking guidance.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the filing alone is unlikely to drive a sustained repricing without additional fundamental news.

03

What to watch

The article does not state whether other insiders bought/sold, whether the sale was part of a broader pattern, or whether the insider’s compensation/vesting schedule explains the transaction.

Relevance 3/10Novelty 3/10Timing: Form 4 filed 2026-08-12 after-hours; sale dated 2026-08-10.

Background

This is an SEC Form 4 insider transaction disclosure for Dolby Laboratories, Inc.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby Laboratories insider Nicholson Ryan sold 1,348 shares at $62.04 on 2026-08-10, per a Form 4 filed 2026-08-12.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal beyond typical insider-selling noise.

Evidence & confidence

The filing is a primary-source Form 4, but the article provides only a single sale size and price, with no accompanying guidance, operational change, or buyback/financing event.

Market effects

Minimal. Insider selling in a single media/tech hardware name typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, but insider sales are often driven by diversification or tax planning rather than bearish fundamentals.

Key entities

  • Dolby Laboratories, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Nicholson Ryan

    VP, CAO and Corp. Controller who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We continue to execute against our full-year obje